Is Legend Biotech Corporation (LEGN) a Buy, Sell, or Hold?
NASDAQ : LEGN
Legend Biotech Corporation — Analyst Ratings
$19.06 USD
$0.51 (2.75%)
- Volume
- 784.13K
- Average Volume
- 3.07M
- Market Capitalization
- $3.53B
- P/E Ratio
- -14.01
- Dividend Yield
- 0.00%
- Price Target
- $58.50
- Year High
- $39.16
- Year Low
- $16.24
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.13
Analyst Consensus Summary
Consensus Rating
Strong Sell
19 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-67.4%
vs Current Price
Price Target
$58.50
Average TargetPrice Target Range
Lowest Target
$24.00
-20.6% DOWNSIDE
Average Target
$58.50
Median Estimate
Highest Target
$70.00
-72.8% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 19
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 15 | 4 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Raymond James | Sean McCutcheon | $58 | $18.8693 | 2026-07-27 09:55 AM | 207.4% |
| RBC Capital | Leonid Timashev | $63 | $28.04 | 2026-07-07 07:30 AM | 124.7% |
| UBS | Ashwani Verma | $49 | $36.28 | 2026-06-03 06:50 AM | 35.1% |
| RBC Capital | Leonid Timashev | $64 | $28.6401 | 2026-05-13 09:01 AM | 123.5% |
| Morgan Stanley | Terence Flynn | $48 | $27.555 | 2026-05-13 08:02 AM | 74.2% |